Professor Colin Dayan
Prosiectau fel Prif Ymchwiliwr
- Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger, smarter, faster (01.05.2019 - 30.04.2023)
- Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED) trial (01.10.2014 - 30.06.2015)
- Common variation in thyroid hormone bioavailability: Effects on key health outcomes (01.07.2012 - 30.09.2015)
- Defining the efficacy and mechanisms of peptide immunotherapy for type 1 Diabetes: an experimental medicine study (01.07.2021 - 30.06.2025)
- Diabetes Research Unit (01.04.2015 - 31.03.2020)
Prosiectau fel Cyd-Ymchwiliwr
- Microneedle delivery of antigen-specific immunotherapy for type 1 diabetes (01.10.2014 - 30.09.2018)
- A new window into the immune response funding during Type 1 Diabetes (01.11.2017 - 31.05.2019)
- B cells in newly diagnosed type 1 diabetes (01.03.2012 - 31.07.2016)
- Bringing immunotherapy for type 1 diabetes into the clinic: New windows into the immune response (01.05.2018 - 30.04.2019)
- Cardiovascular disease research (01.11.2013 - 31.10.2016)